(19) demonstrated the prognostic and predictive value of PBRM1 in ccRCC in the same year, more and more researchers are exploring relevant genes, which could be hallmarks of immune targeted therapy of PBRM1-mutant ccRCC. Here, PBRM1 is linked to nonpapillary renal cell carcinoma.